Cascades Earnings Beat Covers Up a Messier Picture Than the Headline Suggests

The Q1 earnings call in May set the tone. Management expected Q2 to be "modestly lower" than a rough first quarter. They pointed to restrained consumer spending, cost volatility, and the challenge of getting to their 2.5x–3.0x leverage target. The outlook was cautious to the point of conservatism.

Then came August 6th.

Adjusted EPS of CAD 0.24 — compared to consensus of CAD 0.065. That's a 269% beat. Revenue of CAD 1.219 billion, above the CAD 1.2 billion estimate. Packaging segment Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization — a rough cash-earnings proxy) rose 16% sequentially to CAD 120 million. And management raised its annual run-rate EBITDA target to exceed CAD 600 million in the second half, higher than anyone expected.

The momentum narrative isn't manufactured. But the question isn't whether Cascades had a strong quarter. The question is whether the stock's setup still offers asymmetric risk/reward after a 9.8% pop the day after earnings, with a new tariff threat looming and leverage still well above management's target range.

What Actually Drove the Turnaround

Packaging is the engine. Cascades grew North American box shipments 8.4% year-over-year on a comparable basis, versus 5.5% industry growth. That's market share gains, not just riding a sector tailwind. Bear Island mill hit 95% capacity with further improvements in July. Greenpac is running at record levels. The segment's EBITDA margin expanded to 15.5% from 14.4% in Q1.

What makes this different from a seasonal blip: pricing power is stacking. Cascades announced its third containerboard price increase of 2026 — CAD 110 per ton for linerboard and white paper grades, CAD 140 per ton for medium — effective September 8th. Previous increases weren't fully recognized in the market, but with approximately 75% of containerboard customers on contracts that track price movements, the new increases should flow through starting in Q4.

The volume story matters even more than pricing. Record production at core facilities and successful new customer onboarding mean Cascades isn't just squeezing margins — it's filling capacity. For a turnaround thesis, capacity utilization moving toward the high end is a leading indicator. More volume at stable or improving margins compounds faster than price increases alone.

Tissue is the drag, and it hasn't cracked, exactly. Adjusted EBITDA of CAD 35 million was down CAD 3 million year-over-year. Elevated transportation costs and raw material inflation — recycled fiber up more than 10% sequentially, hardwood pulp and eucalyptus up to 15% — ate into volume and pricing gains. The margin held at 8.6%, which is below Packaging but stable. Away-from-home shipments surged 16% sequentially. Pryor, Oklahoma production was up 19% versus Q3 2025.

Tissue isn't a disaster. It's a cost-management exercise that's working incrementally rather than dramatically. The CAD 25 million in profitability improvements expected in 2026, on top of CAD 30 million in 2025, are coming through. It's just not the headline-grabbing recovery story Packaging delivered.

The Valuation: Cheap for a Reason, But Maybe Not for the Reasons You Think

Cascades trades at approximately 13.7x to 14.2x trailing earnings with a market cap of CAD 1.73 billion and enterprise value of CAD 3.64 billion against annual revenue of roughly CAD 4.8 billion. That's enterprise value at about 0.76x trailing sales — dirt cheap by any standard for a company executing a turnaround.

The discount exists because of the balance sheet. Net debt of CAD 1.879 billion leaves a leverage ratio (net debt to Adjusted EBITDA) of 3.3x. Management's target is 2.5x–3.0x, which they called "challenging" back in Q1. They're making progress — net debt declined modestly quarter-over-quarter, and asset monetization has generated CAD 154 million against a CAD 230 million target — but the timeline has extended to early 2027.

Here's what this means for the risk/reward: the 0.76x EV/sales multiple prices in a company carrying significant debt with an uncertain deleveraging timeline. But if the CAD 600 million+ annual EBITDA run rate materializes, as H2 guidance suggests, the leverage ratio compresses mechanically. At a CAD 600 million run rate, annualized debt-to-EBITDA drops toward 3.1x before any additional asset sales or cash flow paydown. Combined with the asset monetization push, the 2.5x–3.0x target isn't a pipe dream. It's a function of executing what's already in the plan.

The Tariff Variable

The U.S. announced new 50% tariffs on certain Canadian wood and paper products in late July, with implementation starting August 19th. Cascades acknowledged exposure for some tissue and packaging exports.

Management capped the expected impact at 5% of the adjusted EBITDA run rate, assuming mitigation plans proceed as expected. That translates to roughly CAD 25–30 million annually on a CAD 600 million run rate — material but not existential.

What gives Cascades confidence here that a first-time tariff exposure wouldn't: this company has navigated nearly identical conditions over the past year and a half, when almost all its Canada-to-U.S. shipments faced duties. They know how to shift production between facilities, reroute logistics, and restructure pricing. CEO Hugues Simon described the mitigation plan as a "rather quick implementation" — not the six-to-12 month scramble you'd expect from an unprepared company.

But there's a secondary risk worth flagging: weaker downstream demand from tariff-exposed customers. If U.S. end buyers absorb higher costs or reduce orders, the demand impact could exceed the direct tariff hit. Management is tracking this, and the product-level uncertainty around exactly which SKUs are affected (small rolls taxed, big rolls not) suggests the final picture may not be clear for weeks.

The Setup

Let me be direct about what I'm seeing. The Q2 results aren't a fluke. Packaging market share gains, record production, pricing momentum, and a credibility-boosting earnings beat that reversed a "modestly lower" Q2 forecast — that's a turnaround with operational teeth. The valuation, at 0.76x EV/sales and 14x earnings, doesn't price this in yet because the debt story and tariff cloud are doing the heavy lifting on the discount side.

But the 9.8% post-earnings pop and the tariff uncertainty mean I'm not in a rush to chase. The stock is approaching its 52-week high after a year of compression, and the optimal entry is where tariff clarity or a technical pullback creates a lower-risk setup.

If the tariff impact comes in at or below the 5% EBITDA cap and the H2 run rate exceeds CAD 600 million as guided, the leverage ratio compresses, the multiple re-rates, and the CAD 1.73 billion market cap looks backward-looking. That's the upside case the stock doesn't fully reflect right now.

If demand softens materially from downstream tariff effects, or if raw material inflation accelerates beyond what pricing can offset, the turnaround narrative weakens and the leverage ratio stays elevated. That's the downside I'm watching.

My posture: the thesis is constructive, but I'd wait for a clearer entry point — either tariff resolution that confirms management's capped impact, or a pullback that improves the risk/reward further. The opportunity here is real, and investors with a medium-term horizon shouldn't let it go to waste. But patience on entry is still the better play than chasing a 10% pop into uncertainty.

I'd reassess if H2 EBITDA falls meaningfully short of the CAD 600 million run rate, or if the tariff exposure proves significantly broader than management's current estimate.